BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 23318018)

  • 1. [Reimbursed health expenditures during the last year of life, in France, in the year 2008].
    Ricci P; Mezzarobba M; Blotière PO; Polton D
    Rev Epidemiol Sante Publique; 2013 Feb; 61(1):29-36. PubMed ID: 23318018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and economic burden of cardiovascular diseases in France in 2013 according to the national health insurance scheme database.
    Tuppin P; Rivière S; Rigault A; Tala S; Drouin J; Pestel L; Denis P; Gastaldi-Ménager C; Gissot C; Juillière Y; Fagot-Campagna A
    Arch Cardiovasc Dis; 2016; 109(6-7):399-411. PubMed ID: 27079468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Health care costs in the last year of life--the Dutch experience.
    Polder JJ; Barendregt JJ; van Oers H
    Soc Sci Med; 2006 Oct; 63(7):1720-31. PubMed ID: 16781037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Health system costs by sex, age and proximity to death, and implications for estimation of future expenditure.
    Blakely T; Atkinson J; Kvizhinadze G; Nghiem N; McLeod H; Wilson N
    N Z Med J; 2014 May; 127(1393):12-25. PubMed ID: 24816953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Time to death and health expenditure: an improved model for the impact of demographic change on health care costs.
    Seshamani M; Gray A
    Age Ageing; 2004 Nov; 33(6):556-61. PubMed ID: 15308460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [National Health Insurance expenditures in 1994 for thirty long-term illness].
    Fender P; Païta M; Salanave B; Ganay D; Allemand H
    Sante Publique; 2000 Mar; 12(1):5-19. PubMed ID: 10850139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Life expectancy and health care expenditures: a new calculation for Germany using the costs of dying.
    Breyer F; Felder S
    Health Policy; 2006 Jan; 75(2):178-86. PubMed ID: 15893848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cost of in-patient care in Western Australia in the last years of life: a population-based data linkage study.
    Moorin RE; Holman CD
    Health Policy; 2008 Mar; 85(3):380-90. PubMed ID: 17913279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What has influenced patient health-care expenditures in Japan?: variables of age, death, length of stay, and medical care.
    Sato E; Fushimi K
    Health Econ; 2009 Jul; 18(7):843-53. PubMed ID: 18816581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trends in Medicare payments in the last year of life.
    Lubitz JD; Riley GF
    N Engl J Med; 1993 Apr; 328(15):1092-6. PubMed ID: 8455667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A longitudinal study of the effects of age and time to death on hospital costs.
    Seshamani M; Gray AM
    J Health Econ; 2004 Mar; 23(2):217-35. PubMed ID: 15019753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Health insurance expenses for children in the first five years of life - a cohort-based analysis].
    Reichert J; Schemken M; Manthei R; Steinbronn R; Bucher U; Albrecht M; Rüdiger M
    Z Evid Fortbild Qual Gesundhwes; 2013; 107(7):451-60. PubMed ID: 24238022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Healthcare services funded by Counties Manukau District Health Board for people in the last year of life.
    Chan WC; Jackson G; Winnard D; Anderson P
    N Z Med J; 2011 May; 124(1335):40-51. PubMed ID: 21946681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utilization and costs for children who have special health care needs and are enrolled in a hospital-based comprehensive primary care clinic.
    Berman S; Rannie M; Moore L; Elias E; Dryer LJ; Jones MD
    Pediatrics; 2005 Jun; 115(6):e637-42. PubMed ID: 15930189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of population ageing on future Danish drug expenditure.
    Kildemoes HW; Christiansen T; Gyrd-Hansen D; Kristiansen IS; Andersen M
    Health Policy; 2006 Feb; 75(3):298-311. PubMed ID: 16399170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intensity of Care, Expenditure, and Place of Death in French Women in the Year Before Their Death From Breast Cancer: A Population-Based Study.
    Tanguy-Melac A; Denis P; Fagot-Campagna A; Gastaldi-Ménager C; Laurent M; Tuppin P
    Cancer Control; 2020; 27(1):1073274820977175. PubMed ID: 33356850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hospital expenses towards the end of life.
    Melberg HO; Godager G; Gregersen FA
    Tidsskr Nor Laegeforen; 2013 Apr; 133(8):841-4. PubMed ID: 23612105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Medical expenses by site of cancer and survival time among cancer patients in the last one year of life].
    Yi JJ; Yoo WK; Kim SY; Kim KK; Yi SW
    J Prev Med Public Health; 2005 Feb; 38(1):9-15. PubMed ID: 16312905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cost of multiple sclerosis in France].
    Fromont A; Lehanneur MN; Rollot F; Weill A; Clerc L; Bonithon Kopp C; Binquet C; Moreau T
    Rev Neurol (Paris); 2014; 170(6-7):432-9. PubMed ID: 24856285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short-term persistence of high health care costs in a nationally representative sample of children.
    Liptak GS; Shone LP; Auinger P; Dick AW; Ryan SA; Szilagyi PG
    Pediatrics; 2006 Oct; 118(4):e1001-9. PubMed ID: 17015496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.